Pressmeddelande

ExpreS2ion changes dates for the annual general meeting and the publication of the annual report for 2023

Cision Publicerad: 16 Apr 16:40

Hørsholm, Denmark, 16 April 2024 – ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") announces that the Board of Directors of ExpreS2ion has resolved to postpone the Company's annual general meeting and consequently also the publication of the annual report for 2023 due to administrative and practical reasons.

The new date for the annual general meeting is 30 May 2024 and the new date for publication of the annual report for 2023 is 8 May 2024. An updated financial calendar is available on the Company's website, www.expres2ionbio.com.

Certified Adviser
Svensk Kapitalmarknadsgranskning AB

The information was sent for publication, through the agency of the contact persons set out above, at the time stated by the Company’s news distributor, Cision, at the publication of this press release.

Bifogade filer

240416 EXPRS2 PR AGM AR Date Changehttps://mb.cision.com/Main/14402/3962527/2736405.pdf

Nyheter om ExpreS2ion Biotech

Läses av andra just nu

Innehåller annonslänkar. Investeringar innebär risk (se här)

Tips: 50% rabatt hos fondroboten Opti

Dags att komma igång med sparande? Fondroboten Opti erbjuder en populär spartjänst som är perfekt för regelbundet månadssparande. Just nu får nya kunder som använder Börskollens unika kampanjkod BORSKOLLEN50 automatiskt 50 % rabatt på Optis avgift i 3 månader!